Putting the Applied Biosystems TaqPath COVID-19 kit to the test: clinical performance against the competition

Supported by Thermo Fisher Scientific


As SARS-CoV-2 continues to spread around the globe, COVID-19 testing remains a cornerstone for helping to control the spread of this novel coronavirus. In this workshop ARUP Laboratories will share their experiences using the Emergency Use Authorized TaqPath COVID-19 Combo Kit. They will share clinical performance and comparison data with two other SARS-CoV-2 real-time PCR-based tests, including performance data with regards to the "two of three" infected patient gold standard. Additionally, Thermo Fisher Scientific will discuss our rapidly expanding COVID-19 testing portfolio which aims to assist with the growing testing demands of the medical community.


Maggie Pochyla, MBA
Associate Director, Global Market Dev. and Team Lead, COVID-19 NPI Execution & Marketing Operations
Thermo Fisher Scientific